» Articles » PMID: 35330384

Clinical Approaches to Late-Onset Psychosis

Overview
Journal J Pers Med
Date 2022 Mar 25
PMID 35330384
Authors
Affiliations
Soon will be listed here.
Abstract

Psychosis can include schizophrenia, mood disorders with psychotic features, delusional disorder, active delirium, and neurodegenerative disorders accompanied by various psychotic symptoms. Late-onset psychosis requires careful intervention due to the greater associated risks of secondary psychosis; higher morbidity and mortality rates than early-onset psychosis; and complicated treatment considerations due to the higher incidence of adverse effects, even with the black box warning against antipsychotics. Pharmacological treatment, including antipsychotics, should be carefully initiated with the lowest dosage for short-term efficacy and monitoring of adverse side effects. Further research involving larger samples, more trials with different countries working in consortia, and unified operational definitions for diagnosis will help elaborate the clinical characteristics of late-onset psychosis and lead to the development of treatment approaches.

Citing Articles

Digital Health Interventions for Informal Family Caregivers of People With First-Episode Psychosis: Systematic Review on User Experience and Effectiveness.

Munchenberg P, Yessimova D, Panteli D, Kurth T JMIR Ment Health. 2024; 11:e63743.

PMID: 39607998 PMC: 11638689. DOI: 10.2196/63743.


Serum Interleukin-6 in Schizophrenia: Associations with Clinical and Sociodemographic Characteristics.

Zhilyaeva T, Rukavishnikov G, Manakova E, Mazo G Consort Psychiatr. 2024; 4(4):5-16.

PMID: 38618638 PMC: 11009974. DOI: 10.17816/CP11067.


Exploring the Genetic Landscape of Mild Behavioral Impairment as an Early Marker of Cognitive Decline: An Updated Review Focusing on Alzheimer's Disease.

Angelopoulou E, Koros C, Hatzimanolis A, Stefanis L, Scarmeas N, Papageorgiou S Int J Mol Sci. 2024; 25(5).

PMID: 38473892 PMC: 10931648. DOI: 10.3390/ijms25052645.

References
1.
Gournellis R, Oulis P, Rizos E, Chourdaki E, Gouzaris A, Lykouras L . Clinical correlates of age of onset in psychotic depression. Arch Gerontol Geriatr. 2010; 52(1):94-8. DOI: 10.1016/j.archger.2010.02.007. View

2.
Copeland J, Dewey M, Scott A, Gilmore C, Larkin B, Cleave N . Schizophrenia and delusional disorder in older age: community prevalence, incidence, comorbidity, and outcome. Schizophr Bull. 1998; 24(1):153-61. DOI: 10.1093/oxfordjournals.schbul.a033307. View

3.
Jonas K, Clouston S, Li K, Fochtmann L, Lencz T, Malhotra A . Apolipoprotein E-ε4 allele predicts escalation of psychotic symptoms in late adulthood. Schizophr Res. 2018; 206:82-88. PMC: 6525644. DOI: 10.1016/j.schres.2018.12.010. View

4.
Ayalew M, Le-Niculescu H, Levey D, Jain N, Changala B, Patel S . Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry. 2012; 17(9):887-905. PMC: 3427857. DOI: 10.1038/mp.2012.37. View

5.
Van Citters A, Pratt S, Bartels S, Jeste D . Evidence-based review of pharmacologic and nonpharmacologic treatments for older adults with schizophrenia. Psychiatr Clin North Am. 2005; 28(4):913-39, ix. DOI: 10.1016/j.psc.2005.08.001. View